NVRO logo

Nevro (NVRO) EBITDA

Annual EBITDA

-$78.31 M
-$99.33 M-472.50%

December 31, 2023

Summary

Performance

1-Year Change

-472.5%

3-Year Change

-50%

5-Year Change

-129.32%

15-Year Change

-242.85%

NVRO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

23.25%
NVRO annual EBITDA is higher than 23.25% of companies in Healthcare sector

High & Low

All-time High

$21.02 M
NVRO annual EBITDA is currently -472.50% below its historical high of $21.02 million

3-Year Low

-$102.40 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NVRO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 21, 2025
NVRO next annual earnings announcement is scheduled for Feb 21, 2025

OtherNVROprofitabilitymetrics:

Annual Revenue

$425.17 M
NVRO annual revenue is $425.17 million

Annual Net Income

-$92.21 M
NVRO annual net profit is -$92.21 million

Annual EBIT

-$89.84 M
NVRO annual earnings before interest & taxes is -$89.84 million

Annual EPS

-$2.56
NVRO annual earnings per share is -$2.56

Quarterly EBITDA

-$4.79 M
+$4.21 M+46.83%

September 30, 2024

Summary

Performance

3-Month Change

+46.83%

1-Year Change

+74.65%

3-Year Change

+89.15%

5-Year Change

+62.48%

NVRO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.22%
NVRO quarterly EBITDA is higher than 48.22% of companies in Healthcare sector

High & Low

All-time High

$86.25 M
NVRO quarterly EBITDA is currently -105.55% below its historical high of $86.25 million

3-Year Low

-$30.46 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NVRO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
NVRO next earnings announcement is scheduled for Feb 21, 2025

OtherNVROprofitabilitymetrics:

Quarterly Revenue

$96.91 M
NVRO quarterly revenue is $96.91 million

Quarterly Net Income

-$15.34 M
NVRO quarterly net profit is -$15.34 million

Quarterly EBIT

-$8.06 M
NVRO quarterly earnings before interest & taxes is -$8.06 million

Quarterly EPS

-$0.41
NVRO quarterly earnings per share is -$0.41

TTM EBITDA

-$37.46 M
+$14.09 M+27.33%

September 30, 2024

Summary

Performance

3-Month Change

+27.33%

1-Year Change

+55.31%

3-Year Change

+51.17%

5-Year Change

+55.06%

NVRO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.46%
NVRO TTM EBITDA is higher than 37.46% of companies in Healthcare sector

High & Low

All-time High

$21.30 M
NVRO TTM EBITDA is currently -275.81% below its historical high of $21.30 million

3-Year Low

-$118.72 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NVRO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
NVRO next earnings announcement is scheduled for Feb 21, 2025

OtherNVROprofitabilitymetrics:

TTM Revenue

$419.15 M
NVRO TTM revenue is $419.15 million

TTM Net Income

-$69.31 M
NVRO TTM net profit is -$69.31 million

TTM EBIT

-$51.54 M
NVRO TTM earnings before interest & taxes is -$51.54 million

TTM EPS

-$1.89
NVRO TTM earnings per share is -$1.89

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$78.31 M
NVRO annual EBITDA is -$78.31 million

Annual Net Income

-$92.21 M
NVRO annual net profit is -$92.21 million

Annual Interest Expense

$8.01 M
NVRO annual interest expense is $8.01 million

Annual Income Tax

-$5.65 M
NVRO annual income tax is -$5.65 million

Annual D&A

$11.54 M
NVRO annual depreciation & amortization is $11.54 million

NVRO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-472.5%+74.7%+55.3%
3 y3 years-50.0%+89.2%+51.2%
5 y5 years-129.3%+62.5%+55.1%

NVRO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-472.5%+23.5%-105.5%+84.3%-275.8%+68.5%
5 y5-year-472.5%+23.5%-105.5%+89.2%-275.8%+68.5%
alltimeall time-472.5%+23.5%-105.5%+89.2%-275.8%+68.5%

Nevro EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.79 M(-46.8%)
-$37.46 M(-27.3%)
Jun 2024
-
-$9.00 M(-38.1%)
-$51.55 M(-17.4%)
Mar 2024
-
-$14.55 M(+59.4%)
-$62.39 M(-20.3%)
Dec 2023
-$78.31 M(-472.5%)
-$9.12 M(-51.7%)
-$78.31 M(-6.6%)
Sep 2023
-
-$18.88 M(-4.9%)
-$83.82 M(-493.4%)
Jun 2023
-
-$19.85 M(-34.8%)
$21.30 M(+3.4%)
Mar 2023
-
-$30.46 M(+108.2%)
$20.60 M(-2.0%)
Dec 2022
$21.02 M(-120.5%)
-$14.63 M(-117.0%)
$21.02 M(+80.3%)
Sep 2022
-
$86.25 M(-519.6%)
$11.66 M(-109.8%)
Jun 2022
-
-$20.55 M(-31.6%)
-$118.72 M(+6.2%)
Mar 2022
-
-$30.04 M(+25.2%)
-$111.75 M(+9.1%)
Dec 2021
-$102.40 M(+96.1%)
-$24.00 M(-45.6%)
-$102.40 M(+33.5%)
Sep 2021
-
-$44.13 M(+224.8%)
-$76.71 M(+125.8%)
Jun 2021
-
-$13.59 M(-34.3%)
-$33.97 M(-36.2%)
Mar 2021
-
-$20.68 M(-1326.1%)
-$53.26 M(+2.0%)
Dec 2020
-$52.20 M(-37.4%)
$1.69 M(-221.8%)
-$52.20 M(-16.2%)
Sep 2020
-
-$1.39 M(-95.8%)
-$62.30 M(-15.4%)
Jun 2020
-
-$32.87 M(+67.4%)
-$73.67 M(+15.4%)
Mar 2020
-
-$19.63 M(+133.4%)
-$63.85 M(-23.4%)
Dec 2019
-$83.36 M(+144.1%)
-$8.41 M(-34.0%)
-$83.36 M(+2.4%)
Sep 2019
-
-$12.76 M(-44.7%)
-$81.38 M(+7.6%)
Jun 2019
-
-$23.05 M(-41.1%)
-$75.64 M(+27.6%)
Mar 2019
-
-$39.14 M(+508.5%)
-$59.29 M(+73.6%)
DateAnnualQuarterlyTTM
Dec 2018
-$34.15 M(+49.5%)
-$6.43 M(-8.3%)
-$34.15 M(+20.3%)
Sep 2018
-
-$7.01 M(+4.6%)
-$28.39 M(+18.0%)
Jun 2018
-
-$6.71 M(-52.1%)
-$24.07 M(-5.7%)
Mar 2018
-
-$14.00 M(+1989.1%)
-$25.51 M(+11.7%)
Dec 2017
-$22.84 M(+3.6%)
-$670.00 K(-75.1%)
-$22.84 M(-19.9%)
Sep 2017
-
-$2.69 M(-67.0%)
-$28.53 M(+7.9%)
Jun 2017
-
-$8.15 M(-28.0%)
-$26.43 M(+3.9%)
Mar 2017
-
-$11.33 M(+78.1%)
-$25.44 M(+15.4%)
Dec 2016
-$22.04 M(-65.0%)
-$6.36 M(+974.3%)
-$22.04 M(-22.1%)
Sep 2016
-
-$592.00 K(-91.7%)
-$28.31 M(-38.5%)
Jun 2016
-
-$7.16 M(-9.7%)
-$46.01 M(-20.2%)
Mar 2016
-
-$7.93 M(-37.2%)
-$57.65 M(-8.4%)
Dec 2015
-$62.92 M(+110.1%)
-$12.63 M(-31.0%)
-$62.92 M(+7.9%)
Sep 2015
-
-$18.29 M(-2.7%)
-$58.31 M(+22.1%)
Jun 2015
-
-$18.81 M(+42.5%)
-$47.75 M(+31.9%)
Mar 2015
-
-$13.20 M(+64.6%)
-$36.20 M(+20.9%)
Dec 2014
-$29.95 M(+19.3%)
-$8.02 M(+3.8%)
-$29.95 M(+5.3%)
Sep 2014
-
-$7.72 M(+6.3%)
-$28.45 M(+9.1%)
Jun 2014
-
-$7.26 M(+4.5%)
-$26.08 M(+38.6%)
Mar 2014
-
-$6.95 M(+6.6%)
-$18.82 M(+58.5%)
Dec 2013
-$25.10 M(+31.5%)
-$6.52 M(+21.7%)
-$11.87 M(+121.7%)
Sep 2013
-
-$5.35 M
-$5.35 M
Dec 2012
-$19.09 M
-
-

FAQ

  • What is Nevro annual EBITDA?
  • What is the all time high annual EBITDA for Nevro?
  • What is Nevro annual EBITDA year-on-year change?
  • What is Nevro quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Nevro?
  • What is Nevro quarterly EBITDA year-on-year change?
  • What is Nevro TTM EBITDA?
  • What is the all time high TTM EBITDA for Nevro?
  • What is Nevro TTM EBITDA year-on-year change?

What is Nevro annual EBITDA?

The current annual EBITDA of NVRO is -$78.31 M

What is the all time high annual EBITDA for Nevro?

Nevro all-time high annual EBITDA is $21.02 M

What is Nevro annual EBITDA year-on-year change?

Over the past year, NVRO annual EBITDA has changed by -$99.33 M (-472.50%)

What is Nevro quarterly EBITDA?

The current quarterly EBITDA of NVRO is -$4.79 M

What is the all time high quarterly EBITDA for Nevro?

Nevro all-time high quarterly EBITDA is $86.25 M

What is Nevro quarterly EBITDA year-on-year change?

Over the past year, NVRO quarterly EBITDA has changed by +$14.09 M (+74.65%)

What is Nevro TTM EBITDA?

The current TTM EBITDA of NVRO is -$37.46 M

What is the all time high TTM EBITDA for Nevro?

Nevro all-time high TTM EBITDA is $21.30 M

What is Nevro TTM EBITDA year-on-year change?

Over the past year, NVRO TTM EBITDA has changed by +$46.36 M (+55.31%)